Assessing Enterorenal Syndrome in Sepsis Using Ultrasound
A Study on the Significance of Joint Evaluation of Gastrointestinal Ultrasound Results and Renal Artery Resistance Index for Assessing the Intestinal-renal Syndrome in Sepsis Patients
This study is testing how ultrasound can help doctors understand and track kidney problems in patients with sepsis from abdominal infections to improve their care in the ICU.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 74 (estimated) |
| Ages | 14 Years to 85 Years |
| Sex | All |
| Sponsor | Zhangzhou Municipal Hospital Academic / other |
| Locations | 1 site (Zhangzhou, Fujian) |
| Trial ID | NCT06505512 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates patients with sepsis caused by abdominal infections by utilizing gastrointestinal ultrasound and renal artery resistance index measurements. Patients are categorized into survival and death groups based on various ultrasound parameters, including gastric antrum size and colon function, to assess the progression of enterorenal syndrome. The study aims to provide objective data to inform clinical decision-making and improve patient outcomes in critical care settings. Data is collected at multiple time points during ICU admission to monitor changes and outcomes.
Who should consider this trial
Good fit: Ideal candidates include adult patients diagnosed with intra-abdominal infections and experiencing sepsis or septic shock.
Not a fit: Patients with open chest or abdominal injuries, advanced tumors, uremia, or who are pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and management of enterorenal syndrome in septic patients, potentially improving survival rates.
How similar studies have performed: While similar studies have explored the relationship between gastrointestinal function and renal outcomes in sepsis, this specific approach combining ultrasound metrics is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with intra-abdominal infections * Patients with sepsis or septic shock Exclusion Criteria: * Patients with open chest or abdominal injury * Patients with advanced tumor * Patients with uremia * Pregnant women
Where this trial is running
Zhangzhou, Fujian
- Qingjiang Zheng — Zhangzhou, Fujian, China (Recruiting)
Study contacts
- Principal investigator: Hui Jiang, Dr. — the Ethnics Committee of Zhangzhou Municipal Hospital of Fujian Province
- Study coordinator: De Kang, Dr.
- Email: cdkant@163.com
- Phone: +8613960163029
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.